Ya-Ling Han

Showing 1-7 of 7 articles

Coronary interventions

Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial

Zhang Y-J, Wang X-Z, Fu G, Jing Q, Wang G, Jin C-Y, Xie L-H, Cai J-Z, Xu B, Han Y-L

November 20, 2016 | 10.4244/EIJV12I10A209

Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study

Xu B, Yang Y, Han Y-L, Lu S-Z, Li B, Liu Q, Zhu G-Y, Cui J-Y, Li L, Zhao Y-L, Kirtane A

May 20, 2014 | 10.4244/EIJV10I1A12

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y-L, Zhong S-L

September 27, 2013 | 10.4244/EIJV9I5A90

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation

Liang Z-Y, Han Y-L, Zhang X-L, Li Y, Yan C-H, Kang J

July 26, 2013 | 10.4244/EIJV9I3A53

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

Gao R, Xu B, Lansky A, Yang Y, Ma C-S, Han Y-L, Chen S, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M

May 21, 2013 | 10.4244/EIJV9I1A12

Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study

Zhu X-Y, Qin Y, Han Y-L, Zhang D-Z, Wang P, Liu Y-F, Xu Y-W, Jing Q, Xu K, Gersh B, Wang X-Z

March 22, 2013 | 10.4244/EIJV8I11A195

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study

Han Y-L, Zhang L, Yang L-X, Liu H-L, Qu P, Li W-M, Jiang T, Li S-M, Jing Q, Zhang Q-Y, Xu B, Li Y, Gao R

November 20, 2012 | 10.4244/EIJV8I7A124

1

Latest news

Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...

Optimising the delivery of self-expanding valves according to vascular access

November 20, 2020

Fatal Acute Mesenteric Ischemia Following Transcatheter Aortic Valve Replacement

November 25, 2020

Patient preferences and Heart Team decision

November 20, 2020

Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more

(Thanks to the support of Biotronik)

November 12, 2020

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Cardiovascular trials and COVID-19

Alexandra Lansky

November 25, 2020

This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...

November 24, 2020

Valvular disease